BLFS · Nasdaq
It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
BioLife Solutions, Inc. (the "Company') is unable to file its Quarterly Report Form 10-Q for the three months ended March 31, 2023 within the prescribed time period without unreasonable effort or expense due to a miscommunication with the Company’s financial printer. The Form 10-Q was otherwise complete, executed, and ready to be filed with the Commission prior to the 5:30 p.m. EDT deadline. The Company will file its Quarterly Report on or before the fifth calendar day following the prescribed due date
NT 10-Q, filed 2023-05-11 · accounts not ready
BioLife Solutions, Inc. (the "Company') is unable to file its Quarterly Report Form 10-Q for the three months ended March 31, 2023 within the prescribed time period without unreasonable effort or expense due to a miscommunication with the Company’s financial printer. The Form 10-Q was otherwise complete, executed, and ready to be filed with the Commission prior to the 5:30 p.m. EDT deadline. The Company will file its Quarterly Report on or before the fifth calendar day following the prescribed due date
BioLife Solutions, Inc. (the “Company”) is unable to file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”) within the prescribed time period without unreasonable effort or expense due to the continued assessment of impairment charges arising from its merger with Global Cooling Inc. and integration of operations from prior year acquisitions. The Company is in the process of completing the financial statements to be included therein. The Company’s management is also in the process of assessing the effectiveness of the Company’s internal control over financial reporting. Although the assessment is not yet complete, the Company expects to report material weaknesses in the Company’s internal control over financial reporting. The Company expects to file the 2022 Form 10-K as soon as possible, but no later than March 31, 2023, the fifteenth calendar day following the prescribed due date of the 2022 Form 10-K
2022-04-07auditor changed or resigned SEC →
BioLife Solutions, Inc. (the “Company”) is unable to file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”) within the prescribed time period without unreasonable effort or expense. The Company is in the process of completing the financial statements to be included therein. The Company’s management is also in the process of assessing the effectiveness of the Company’s internal control over financial reporting. Although the assessment is not yet complete, the Company expects to report material weaknesses in the Company’s internal control over financial reporting. The Company expects to file the 2021 Form 10-K as soon as possible, but no later than March 16, 2022, the fifteenth calendar day following the prescribed due date of the 2021 Form 10-K
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice